Roopa Industries

Roopa Industries Non-Current Assets

The Non-Current Assets of Roopa Industries (530991.BO) as of Nov 3, 2026 is -308.39 M INR. In the previous year, Non-Current Assets was -581.20 M INR — a change of -46.94% (higher).

Non-Current Assets

-308.39 MINR

YoY

-46.94%

Last updated:

Non-Current Assets of Roopa Industries is 2026 -308.39 M INR. Non-Current Assets of Roopa Industries was 2025 -581.20 M INR. It decreases by -46.94% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Roopa Industries Stock analysis

What does Roopa Industries do? Roopa Industries Ltd. manufactures pharmaceutical products, focusing on bulk drugs and drug intermediates. The company produces N,N-dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is used by manufacturers of Cephalosporin antibiotics and Statins, while Bromine And Its Derivatives serve agrochemicals, dyes, medical and veterinary products, water purification, and pesticides. Glucosamine is a key nutraceutical product. The primary buyers include pharmaceutical manufacturers, agrochemical companies, and producers of medical and veterinary compounds. The company's revenue streams come from the sale of these specialized chemical products to industries requiring bulk drugs and intermediates. Triphenyl Phosphine supports antibiotic and statin production, making it essential for pharmaceutical firms. Bromine And Its Derivatives cater to diverse sectors like agriculture, water treatment, and disinfection, with significant demand from agrochemical and medical product manufacturers. Glucosamine, as a sheet anchor product, drives sales in the nutraceutical market. Roopa Industries targets the pharmaceutical, agrochemical, and medical sectors with its product portfolio. The firm's focus on bulk drugs and intermediates positions it as a supplier to manufacturers of antibiotics, statins, and nutraceuticals. Its products are integral to the production of Cephalosporin group antibiotics, Statins, and various agrochemical applications, ensuring consistent demand from established industrial buyers. Roopa Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Roopa Industries stock

Non-Current Assets of Roopa Industries is -308.39 M INR in 2026.

Non-Current Assets of Roopa Industries changed from -581.20 M INR to -308.39 M INR, representing a -46.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Non-Current Assets Roopa Industries since 2006 – with annual values, charts, and detailed analysis.

Non-current assets are long-term resources not expected to be converted to cash within one year, including property, equipment, and long-term investments.

Non-Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Non-Current Assets's Roopa Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Roopa Industries

All Key Metrics — Roopa Industries